Arrowhead Pharmaceuticals (NasdaqGS:ARWR) Update / Briefing November 18, 2025 01:30 PM ET Company ParticipantsAvi Novick - Biotech Equity Research AssociateJames Hamilton - Chief Medical Officer and Head of R&DAndy Davis - SVP and Head of Global Cardiometabolic FranchiseVince Anzalone - VP of Finance and Investor RelationsPeyton Bhonsack - VP of Biotechnology Equity ResearchPrakhar Agrawal - Managing DirectorBruce Given - Interim Chief Medical ScientistMorgan Lamberti - Equity Research AssociateChristopher ...